Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer

Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer

Abstract Background Solute Carrier Family 6 Member 1 (SLC6A1) has been identified as a cancer-promoting gene in various human cancers, such as clear cell renal cell carcinoma and ovarian cancer. However, its roles in prostate cancer (PCa) has not been fully elucidated. The aim of this study was to i...

Full description

Bibliographic Details
Main Authors: Chaojiang Chen, Zhiduan Cai, Yangjia Zhuo, Ming Xi, Zhuoyuan Lin, Funeng Jiang, Zezhen Liu, Yueping Wan, Yu Zheng, Jianxin Li, Xing Zhou, Jianguo Zhu, Weide Zhong
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Cancer
Subjects:
Prostate cancer
Solute carrier family 6 member 1
Prognosis
Chemotherapy resistance
Online Access:http://link.springer.com/article/10.1186/s12885-020-06776-7

Internet

http://link.springer.com/article/10.1186/s12885-020-06776-7

Similar Items